News

Pfizer has gained FDA approval for Eucrisa, a new eczema treatment which could achieve peak annual sales of $2 billion a year. The drug is significant because it is the first non-steroidal therapy ...
When a new eczema drug called Dupixent finally became available to Sawyer a few years ago, his turnaround was fast and dramatic. Within a week, his itchiness and redness started calming down.
Nektar Therapeutics (NASDAQ:NKTR) is one of the best hot stocks to buy according to Wall Street analysts. On June 24, Nektar ...
NEW YORK (CBSNewYork)-- Treatments have not always been great for adults suffering from eczema. However, as CBS2's Dr. Max Gomez reports, a new drug may revolutionize the treatment for the very ...
A new drug that scientists hope will relieve the debilitating itching of chronic eczema has shown promising results in early trials. Dupilumab, which is injected, interferes with the activity of ...
New eczema drug from Eli Lilly receives FDA approval for children and adults Reuters On Friday, the U.S. Food and Drug Administration approved Eli Lilly's eczema drug for use in adults and ...
The FDA approved a new, injectable drug on Tuesday to treat serious cases of eczema. The FDA approved a new drug to treat eczema Lester V. Bergman / Getty Images March 28, 2017, 2:53 PM EDT ...
Those with severe eczema can suffer mightily from itching, which leads to scratching, which makes it worse. Anti-inflammatory steroids are the go-to drugs (but they have many nasty, long-term side ...
Regeneron Pharmaceuticals (NASDAQ: REGN)and collaboration partner Sanofi (NYSE: SNY) got welcome news this week when the FDA gave their new eczema drug, Dupixent, a green light. The approval ...
Dupixent has been described as the first of its kind to treating eczema or atopic dermatitis for patients who do not respond to atopical steroids. Drug developer Regeneron Pharmaceuticals won ...